Filtros de búsqueda

Lista de obras de Vasilios G. Athyros

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses

artículo científico publicado en 2011

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary

scientific article published on 01 September 2011

11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?

artículo científico publicado en 2012

A comparison of the aldosterone-blocking agents eplerenone and spironolactone.

artículo científico publicado en 2009

A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAS

scientific article published on 01 August 2007

Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI.

artículo científico publicado en 2013

Additional effects of statins in surgical patients

scientific article published on 01 July 2008

Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?

scientific article published on July 2010

Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance

artículo científico publicado en 2011

Alcohol consumption and the heart

artículo científico publicado en 2013

Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors

artículo científico publicado en 2006

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

article by Vasilios G. Athyros et al published 1 April 2007 in Expert Opinion on Pharmacotherapy

Antihypertensive therapy in acute ischemic stroke: where do we stand?

artículo científico publicado en 2018

Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?

scientific article published on 01 July 2008

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.

artículo científico publicado en 2011

Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study

artículo científico publicado en 2011

Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort

artículo científico publicado en 2007

Atherogenesis in renal patients: a model of vascular disease?

scientific article published on 01 April 2008

Atherosclerotic renal artery stenosis: an update on diagnosis and management

artículo científico publicado en 2011

Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?

artículo científico publicado en 2009

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia

artículo científico publicado en 2002

Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients

artículo científico publicado en 2007

Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study

artículo científico publicado en 2001

Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

artículo científico publicado en 2002

Beliefs and attitudes regarding cardiovascular disease risk factors: a health survey in 10,141 Greek men and women (2006-2012).

artículo científico publicado en 2013

Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient

artículo científico publicado en 2005

Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis

artículo científico publicado en 2010

Brain natriuretic peptide and the athlete's heart: a pilot study

artículo científico publicado en 2010

CORONA, statins, and heart failure: who lost the crown?

artículo científico publicado en 2008

Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?

artículo científico publicado en 2008

Cardiovascular benefits of bariatric surgery in morbidly obese patients ⬇️

artículo científico publicado el 23 de febrero de 2011

Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome

artículo científico publicado en 2010

Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients

artículo científico publicado en 2013

Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)

artículo científico publicado en 2018

Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?

scientific article published on 01 April 2008

Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus

scientific article published on 18 November 2008

Colesevelam: a new and improved bile acid sequestrant?

artículo científico

Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease

artículo científico publicado en 2013

Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".

artículo científico publicado en 2012

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

artículo científico publicado en 2011

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

artículo científico publicado en 2010

Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?

artículo científico publicado en 2010

Current treatment for nonalcoholic fatty liver disease

artículo científico publicado en 2011

Definitions of metabolic syndrome: Where are we now?

artículo científico publicado en 2006

Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

artículo científico publicado en 2007

Does metabolic syndrome influence outcome following percutaneous coronary intervention?

artículo científico publicado en 2011

Dry cough as first manifestation of giant-cell arteritis

scientific article published on 01 December 2006

Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment ⬇️

artículo científico publicado en 2011

Dyslipidaemia, hypercoagulability and the metabolic syndrome

artículo científico publicado en 2006

Dysmetabolic iron overload in metabolic syndrome

artículo científico publicado en 2020

Editorial: aliskiren/amlodipine single-pill combinations: more evidence in favour of combination formulations for the treatment of hypertension

scientific article published on 01 November 2012

Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?

artículo científico publicado en 2012

Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study

scientific article published on 01 January 1998

Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors

scientific article published on 25 November 2009

Effect of aldose reductase inhibition on cardiovascular reflex tests in patients with definite diabetic autonomic neuropathy over a period of 2 years

artículo científico publicado en 1998

Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy

artículo científico publicado en 1998

Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

artículo científico publicado en 2004

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

artículo científico publicado en 2006

Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy

artículo científico publicado en 2006

Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction

artículo científico publicado en 1999

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients

artículo científico publicado en 1996

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Ev

scientific article published on 23 September 2006

Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease

artículo científico publicado en 2004

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

artículo científico publicado en 2005

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

artículo científico publicado en 2004

Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients

artículo científico publicado en 2007

Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness

artículo científico publicado en 2013

Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia

artículo científico publicado en 2008

Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study

artículo científico publicado en 2008

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

artículo científico publicado en 2004

Effects of various fibrates on serum alkaline phosphatase activity.

artículo científico publicado en 2002

Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance

artículo científico publicado en 2011

Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

artículo científico publicado en 2006

Endocrine hypertension: diagnosis and management of a complex clinical entity

artículo científico publicado en 2010

Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

artículo científico publicado en 2009

Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism

artículo científico publicado en 2006

Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?

scientific article published on 01 July 2008

Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity

artículo científico publicado en 2012

Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review

artículo científico publicado en 2006

Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study

artículo científico publicado en 2012

Fish oils and vascular disease prevention: an update.

artículo científico publicado en 2007

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

artículo científico publicado en 2011

Has the time come for a new definition of microalbuminuria?

scientific article published on 01 April 2008

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

artículo científico publicado en 2001

Hypertension and hyperhomocysteinemia as risk factors for chronic kidney disease: A dangerous duo?

artículo científico publicado en 2019

Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

artículo científico publicado en 2011

Hyperuricaemia: more than just a cause of gout?

artículo científico publicado en 2013

Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

artículo científico publicado en 2007

Impact of statins on glucose metabolism--a matter of debate

artículo científico publicado en 2011

Implementation of guidelines for the management of arterial hypertension. The impulsion study

scientific article published on 05 May 2009

Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study

artículo científico publicado en 2009

Inflammatory markers and the metabolic syndrome.

artículo científico publicado en 2005

Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study

artículo científico publicado en 2009

Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease

scientific article published on 01 January 2007

Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?

artículo científico publicado en 2011

Is there any association between adiponectin gene polymorphisms and cardiovascular disease?

artículo científico publicado en 2012

JUPITER: major implications for vascular risk assessment

artículo científico publicado en 2009

Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.

artículo científico publicado en 2003

Lipid lowering agents and the endothelium: an update after 4 years

scientific article published on 01 January 2012

Lipid-lowering agents and new onset diabetes mellitus

artículo científico publicado en 2010

Lipid-lowering therapy in patients with peripheral arterial disease

artículo científico publicado en 2005

Lipid-lowering treatment in peripheral artery disease

artículo científico publicado en 2018

Lipoprotein a: where are we now?

artículo científico publicado en 2009

Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis

artículo científico publicado en 2002

Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.

artículo científico publicado en 2011

Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

artículo científico publicado en 2003

Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia

artículo científico publicado en 2002

Management of statin-intolerant high-risk patients

artículo científico publicado en 2010

Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome

artículo científico publicado en 2012

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease

artículo científico publicado en 2012

Metabolic syndrome and arterial stiffness: the past, the present and the future

artículo científico publicado en 2013

Mortality reduction in patients treated with intensive lipid therapy vs usual care. Re: Zhao XQ, Phan BA, Davis J et al. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosi

artículo científico publicado en 2016

Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review.

artículo científico publicado en 2010

NAFLD and Statins

artículo científico publicado en 2020

New developments in the treatment and prevention of vascular disease--part 1

scientific article published on 01 January 2010

New-onset diabetes after transplantation

Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options

artículo científico publicado en 2012

Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment

artículo científico publicado en 2003

Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations

artículo científico publicado en 2013

PCI and stable coronary heart disease--COURAGE to change our minds?

artículo científico publicado en 2007

Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?

artículo científico publicado en 2018

Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate

artículo científico publicado en 2012

Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention

artículo científico publicado en 2013

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.

artículo científico publicado en 2004

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

artículo científico publicado en 2006

Preventing macrovascular complications of diabetes: where do we stand with glycemic control?

artículo científico publicado en 2008

Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?

artículo científico publicado en 2010

Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?

artículo científico publicado en 2008

Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity

artículo científico publicado en 2012

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

artículo científico publicado en 2004

Response to 'Mildly decreased glomerular filtration rate is associated with poor coronary heart disease outcome'

artículo científico publicado en 2012

Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics

artículo científico publicado en 2012

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

artículo científico publicado en 2010

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

scientific article published on 01 September 1997

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

artículo científico publicado en 2011

Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients

artículo científico publicado en 2010

Serum uric acid as an independent predictor of early death after acute stroke

artículo científico publicado en 2007

Should raising high-density lipoprotein cholesterol be a matter of debate?

artículo científico publicado en 2012

Should we expand the concept of coronary heart disease equivalents?

artículo científico

Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial

artículo científico publicado en 2012

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

artículo científico publicado en 2008

Stage of chronic kidney disease and severity of coronary heart disease manifestation

artículo científico publicado en 2012

Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study

artículo científico publicado en 2009

Statin discontinuation: an underestimated risk?

scientific article published on 02 October 2008

Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?

artículo científico publicado en 2010

Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?

artículo científico publicado en 2011

Statin-fibrate combination for mixed dyslipidaemia: a limited option?

artículo científico publicado en 2010

Statin-fibrate combinations in patients with combined hyperlipedemia

artículo científico publicado en 2001

Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention

artículo científico publicado en 2009

Statins and heart failure

artículo científico publicado en 2010

Statins and nonalcoholic fatty liver disease: a bright future?

artículo científico publicado en 2013

Statins and renal function in patients with diabetes mellitus

artículo científico publicado en 2003

Statins and renal function. Is the compound and dose making a difference?

artículo científico publicado en 2007

Statins and solid organ transplantation.

artículo científico publicado en 2006

Statins for non-alcoholic fatty liver disease: a new indication?

artículo científico publicado en 2006

Statins for the prevention of first or recurrent stroke

scientific article published on 01 April 2008

Statins in patients with renal dysfunction

artículo científico publicado en 2012

Targeting vascular risk in patients with metabolic syndrome but without diabetes

artículo científico publicado en 2005

The DEFINE study: a bright future for CETP inhibitors?

artículo científico publicado en 2011

The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study

artículo científico publicado en 2004

The effect of cholesterol-lowering treatment on renal function

artículo científico publicado en 2006

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

scientific article published on 05 September 2006

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

artículo científico publicado en 2004

The natural history of recently diagnosed autonomic neuropathy over a period of 2 years

artículo científico publicado en 1998

The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].

artículo científico

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

artículo científico publicado en 2005

The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions

artículo científico publicado en 2005

Therapeutic options for statin-intolerant patients

artículo científico publicado en 2012

Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk

artículo científico publicado en 2012

To switch (statins) or not to switch? That is the question

artículo científico publicado en 2010

Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes

scientific article published on 01 May 2006

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

artículo científico publicado en 2002

Triglycerides and vascular risk: insights from epidemiological data and interventional studies

artículo científico publicado en 2009

Undertreatment of dyslipidaemia in Greece

artículo científico publicado en 2004

Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult

artículo científico publicado en 2008

Uric acid levels and vascular disease

artículo científico publicado en 2004

Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?

artículo científico publicado en 2010

Vitamin D deficiency, statin-related myopathy and other links with vascular risk

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda